nach oben

Indian Journal of Otolaryngology and Head & Neck Surgery

Erschienen in:

20.01.2019 | Original Article

Early Intratympanic Methylprednisolone in Sudden SNHL: A Frequency-wise Analysis

verfasst von: Anita Bhandari, Satish Jain

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Sudden sensorineural hearing loss is a dire medical emergency which must be treated at the earliest to get better long term hearing results. Our study aims to determine the efficacy of intratympanic steroid (Methylprednisolone) on auditory outcomes in patients of sudden sensorineural hearing loss and study the relation between time of onset of hearing loss to start of therapy and frequency-wise recovery of hearing loss. A prospective cohort clinical study with 33 patients with sudden hearing loss of 30 dB or more were treated with the intratympanic injection of methylprednisolone and the effect of the drug was observed. In this study, 33 patients with sudden onset (unilateral or bilateral) of hearing loss were treated with intratympanic methylprednisolone. The duration at which the drug was administered and the age of the participants was taken into consideration. Main outcome measures included audiometry results at low, medium and high hearing loss frequencies. The specific frequency at which the hearing improvement took place was tabulated. It was observed that hearing improved significantly if the steroid is injected within the first 4 days of onset (p < 0.05) at all the frequencies. A gain of 15 dB or more was achieved in more than 78% patients after injecting methylprednisolone intratympanically. A statistically significant association was found between recovery rate and frequency of hearing loss with patients showing greater improvement at low hearing loss frequency in comparison to mid and high frequencies (p < 0.05). The drug efficacy does not change with the age of the patient.

Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 106(12):772–776CrossRefPubMed

Jaffe B (1973) Clinical studies in sudden deafness. Adv Otorhinolaryngol 20:221–228PubMed

WilsonVetriR L et al (1983) Viral and epidemiological studies of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 91:650–653

Pearlman HB, Kimura R, Fernandez C (1959) Experiments on temporary obstruction of the internal auditory artery. Laryngoscope 69:591–613

Fisch UF (1983) Management of sudden deafness. Otolaryngol Head Neck Surg 91:3–8CrossRefPubMed

Goodhill V, Harris I, Brockman S et al (1973) Sudden deafness and labyrinthine window ruptures. Ann Otol Rhinol Laryngol 82:2–12CrossRefPubMed

Gussen R (1981) sudden hearing loss associated with cochlear membrane rupture: two human temporal bone reports. Arch Otolaryngol 107(598–600):2

Filipo R, Covelli E, Balsamo G, Attanasio G (2010) Intratympanic prednisolone therapy for sudden sensorineural hearing loss: a new protocol. Acta Otolaryngol 130(11):1209–1213. https://doi.org/10.3109/00016481003793766 CrossRefPubMed

HoHG LH, Shu MT, Yang CC, Tsai HT (2004) Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope 114:1184–1189CrossRef

10.

Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N (2005) Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 133:251–259CrossRefPubMed

11.

Battista RA (2005) Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 132:902–905CrossRefPubMed

12.

Choung YH, Park K, Shin YR, Cho MJ (2006) Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Laryngoscope 116:747–752CrossRefPubMed

13.

Dallan I, Bruschini L, Nacci A, Bruschini P, Traino C, Rognini F et al (2006) Trans tympanic steroids as a salvage therapy in sudden hearing loss: preliminary results. ORL J Otorhinolaryngol Relat Spec 68:247–252CrossRefPubMed

14.

Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A et al (2006) Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 134:940–945CrossRefPubMed

15.

Haynes DS, O’ Malley M, Cohen S, Watford K, Labadie RF (2007) Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 117:3–15CrossRefPubMed

16.

Roebuck J, Chang CY (2006) Efficacy of steroid injection on idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 135:276–279CrossRefPubMed

17.

Plaza G, Herráiz C (2007) Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 137:74–78CrossRefPubMed

18.

Kiliç R, Safak MA, O˘guz H, Kargin S, Demirci M, Samim E et al (2007) Intratympanic methylprednisolone for sudden sensorineural hearing loss. Otol Neurotol 28:312–316CrossRefPubMed

19.

Ahn JH, Han MW, Kim JH, Chung JW, Yoon TH (2008) Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol 128:128–131CrossRefPubMed

20.

Battaglia A, Burchette R, Cueva R (2008) Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 29:453–460CrossRefPubMed

21.

Rarey KE, Luttge WG (1989) Presence of type I and type 2/IB receptors for adreno corticosteroid hormones in the inner ear. Hear Res 41:217–221CrossRefPubMed

22.

Stockroos RJ, Albers FW, Schirm J (1998) The etiology of idiopathic sudden sensorineural hearing loss. Experimental herpes simplex virus infection of the inner ear. Am J Otol 19:447–452

23.

Nagura M, Iwasaki S, Wu R, Mizuta K, Umemura K, Hoshino T (1999) Effects of corticosteroid, contrast medium and ATP on focal microcirculatory disorders of the cochlea. Eur J Pharmacol 366:47–53CrossRefPubMed

24.

Tabuchi K, Oikawa K, Uemaetomari I, Tsuji S, Wada T, Hara A (2003) Glucocorticoids and dehydroepiandrosterone sulfate ameliorate ischemia-induced injury of the cochlea. Hear Res 180:51–56CrossRefPubMed

25.

Lamm K, Arnold W (1998) The effect of prednisolone and non-steroidal anti-inflammatory agents on the normal and noise- damaged guinea pig inner ear. Hear Res 115:149–161CrossRefPubMed

26.

Yao X, Buhi WC, Alvarez IM, Curtis LM, Rarey KE (1995) De novo synthesis of glucocorticoid hormone regulated inner ear proteins in rats. Hear Res 86:183–188CrossRefPubMed

27.

Lin DW, Trune DR (1997) Breakdown of stria vascularis blood-labyrinth barrier in C3H/lpr autoimmune disease mice. Otolaryngol Head Neck Surg 117:1–8CrossRef

28.

Trune DR, Wobig RJ, Kempton JB, Hefeneider SH (1999) Steroid treatment improves cochlear function in the MRL.MpJ-Fas (lpr) autoimmune mouse. Hear Res 137:160–166CrossRefPubMed

29.

Shirwany NA, Seidman MD, Tang W (1998) Effect of trans tympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 19:230–235PubMed

30.

El-Hennawi DM, El-Deen MHB, Abou-Halawa AS, Nadeem HS, Ahmed MR (2005) Efficacy of intratympanic methylprednisolone acetate in treatment of drill-induced sensorineural hearing loss in guinea pigs. J Laryngol Otol 119:2–7CrossRefPubMed

31.

Yilmaz I, Yilmazer C, Erkan AN, Aslan SG, Ozluoglu LN (2005) Intratympanic dexamethasone injection effects on transient- evoked otoacoustic emission. Am J Otololaryngol 26:113–117CrossRef

32.

Araujo MFS, Oliveira CA, Bahmad F Jr (2005) Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus. Does it work? Arch Otolaryngol 131:113–117CrossRef

33.

Fukushima M, Kitahara T, Uno Y, Fuse Y, Doi K, Kubo T (2002) Effects of intratympanic injection of steroids on changes in rat inner ear aquaporin expression. Acta Otolaryngol 122:600–606CrossRefPubMed

34.

Sone M, Hayashi H, Yamamoto H, Tominaga M, Nakashima T (2003) A comparative study of intratympanic steroid and NO synthase inhibitor for treatment of cochlear lateral wall damage due to acute otitis media. Eur J Pharmacol 482:313–318CrossRefPubMed

35.

Himeno C, Komeda M, Izumikawa M, Takemura K, Yagi M, Weiping Y et al (2002) Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 167:61–70CrossRefPubMed

36.

Sharma D, Shekhar D, Kumar D, Pal D, Bajpayi D (2017) Role of intratympanic methylprednisolone in sudden sensorineural hearing loss. A clinical study. IOSR J Dent Med Sci 16(05):43–47CrossRef

37.

Kumar D, Singh D, Thakur D (2018) Intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss after failure of intravenous therapy. IOSR J Dent Med Sci 17(2):28–31

38.

Chandrasekhar SS, Rubinstein RY, Kwartler JA, Gatz M, Connelly PE, Huang E et al (2003) Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 122:521–528

39.

Bachmann G, Su J, Zumegen C, Wittekindt C, Michel O (2001) Permeabilitat derrunden Fenster membrane fur Prednisolon-21-Hydrogensuccinat. Prednisolongehalt der Perilymphe nach lokaler Applikation vs. system ischer injektion. HNO 49:538–542CrossRefPubMed

40.

Saijo S, Kimura RS (1981) Distribution of HRP in the inner ear after injection into the middle ear cavity. Acta Otolaryngol 97:593–610CrossRef

41.

Salt AN, Ohyama K, Thalmann R (1991) Radial communication between the peri lymphatic scalae of the cochlea I: estimation by tracer perfusion. Hear Res 56:29–36CrossRefPubMed

42.

Salt AN, Ohyama K, Thalmann R (1991) Radial communication between the peri lymphatic scalae of the cochlea 2: estimation by bolus injection of tracer into the sealed cochlea. Hear Res 56:37–43CrossRefPubMed

43.

Plontke S, Zenner HP (2002) Pharmacokinetic considerations in intratympanic drug delivery to the inner ear. Acta Otorhinolaryngol Belg 56:369–370PubMed

44.

Salt AN, Ma Y (2001) Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res 154:88–97CrossRefPubMed

45.

Shaia FT, Sheehy J (1976) Sudden sensorineural hearing impairment: a report of 1220 cases. Laryngoscope 86:389–398CrossRefPubMed

46.

Fuse T, Aoyagi M, Funakubo T, Sakakibara A, Yoshida S (2010) Short term outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid. ORL J Otorhinolaryngol Relat Spec 64:6–10CrossRef

Titel: Early Intratympanic Methylprednisolone in Sudden SNHL: A Frequency-wise Analysis
verfasst von: Anita Bhandari
Satish Jain
Publikationsdatum: 20.01.2019
Verlag: Springer India
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 3/2019
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-019-01582-5

Neu im Fachgebiet HNO

16.04.2024 | HNO-Chirurgie | Nachrichten

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Early Intratympanic Methylprednisolone in Sudden SNHL: A Frequency-wise Analysis

Abstract

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

A Systematic Literature Review of the Safety and Efficacy of Eustachian Balloon Tuboplasty in Patients with Chronic Eustachian Tube Dysfunction

Computer Algorithms in Assessment of Obstructive Sleep Apnoea Syndrome and Its Application in Estimating Prevalence of Sleep Related Disorders in Population

Role of Proton Pump Inhibitors in Laryngopharyngeal Reflux: Clinical Evaluation in a North Indian Population

High Flow Nasal Cannula: A Game Changer in Airway Surgery

Multi Level Single Stage: Barbed Reposition Pharyngoplasty and Nasal Surgery in Treatment of OSA—Our Experience

Comparison of Functional Organ Preservation by Concomitant Boost Radiotherapy Versus Concurrent Chemoradiation in Locally Advanced Carcinoma of Larynx or Hypopharynx: A Prospective Randomized Study

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO